CRL - Company ID 0001100682
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported net income of -$144.34M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$144.34M | -750.1% |
| FY 2024 | $22.20M | -95.3% |
| FY 2023 | $474.62M | -2.4% |
| FY 2022 | $486.23M | +24.4% |
| FY 2021 | $390.98M | +7.3% |
| FY 2020 | $364.30M | +44.6% |
| FY 2019 | $252.02M | +11.3% |
| FY 2018 | $226.37M | +83.5% |
| FY 2017 |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported net income of -$144.34M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2009 and fiscal 2025, CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s net income declined from $114.44M to -$144.34M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $123.36M |
| -20.3% |
| FY 2016 | $154.76M | +3.7% |
| FY 2015 | $149.31M | +17.8% |
| FY 2014 | $126.70M | +23.2% |
| FY 2013 | $102.83M | +130.5% |
| FY 2010 | -$336.67M | -394.2% |
| FY 2009 | $114.44M | - |